The novel approach of tirzepatide peptide represents a significant advance in the care of diabetes mellitus type 2. Unlike existing therapies, tirzepatide targets two pathways – GLP-1 and GIP – resulting in https://tirzepatidepeptide306260.ja-blog.com/42334514/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment